Celemics, Inc. (KOSDAQ:331920)
South Korea · Delayed Price · Currency is KRW 14,300
-50 (-0.35%)
At close: Sep 3, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 161.8 billion as of September 4, 2026. Its market cap has increased by 567.27% in one year.
Market Cap
161.80B
Enterprise Value
139.90B
Revenue
5.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,300.00
ChartMarket Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 161.80B, a decrease of -19.23%. That is a compound annual growth rate of -3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 161.80B | 629.94% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 832.65B |
| Curiox Biosystems | 832.64B |
| Biodyne | 207.52B |
| M.I.TECH Co.,Ltd | 166.36B |
| BIOBIJOU | 164.74B |
| Synergy Innovation | 139.65B |
| RecensMedical | 107.36B |
| Corentec | 53.56B |